<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1728-8800-2016-1-16-19</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-315</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ХРОНИЧЕСКАЯ СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CHRONIC HEART FAILURE</subject></subj-group></article-categories><title-group><article-title>Взаимосвязь процессов ремоделирования сердца с дисфункцией эндотелия у больных с хронической сердечной недостаточностью</article-title><trans-title-group xml:lang="en"><trans-title>Relation of the heart remodeling and endothelial dysfunction in chronic heart failure patients</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Абдуллаева</surname><given-names>Ч. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Abdullaeva</surname><given-names>Ch. A.</given-names></name></name-alternatives><bio xml:lang="ru"/><email xlink:type="simple">charos27_81@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Камилова</surname><given-names>У. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Kamilova</surname><given-names>U. K.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"><p>1.Tashkent Medical Academy. Tashkent; 2.Republic Specialized Scientific-Practical Medical Center for Internal Medicine and Medical Rehabilitation. Tashkent</p></bio><email xlink:type="simple">umida_kamilova@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ташкентская медицинская академия. Ташкент</institution></aff><aff xml:lang="en"><institution>Tashkent Medical Academy. Tashkent</institution></aff></aff-alternatives><aff xml:lang="ru" id="aff-2"><institution>Ташкентская медицинская академия. Ташкент;&#13;
Республиканский специализиpованный научно-практический медицинский центp теpапии и медицинской реабилитации. Ташкент</institution><country>Uzbekistan</country></aff><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>20</day><month>02</month><year>2016</year></pub-date><volume>15</volume><issue>1</issue><fpage>16</fpage><lpage>19</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Абдуллаева Ч.А., Камилова У.К., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Абдуллаева Ч.А., Камилова У.К.</copyright-holder><copyright-holder xml:lang="en">Abdullaeva C.A., Kamilova U.K.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/315">https://cardiovascular.elpub.ru/jour/article/view/315</self-uri><abstract><sec><title>Цель</title><p>Цель. Изучить взаимосвязь между процессами ремоделирования сердца и дисфункцией эндотелия у больных с хронической сердечной недостаточностью (ХСН).</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Обследованы 103 больных с постинфарктным кардиосклерозом (ПИКС). Все больные были разделены на 3 группы по функциональному классу (ФК) ХСН: I группу составили 28 больных c ХСН I ФК, II группу – 46 больных II ФК и III группу – 29 больных с III ФК по классификации NYHA. Всем больным проводили эхокардиографию, допплерографию плечевой аpтеpии.</p></sec><sec><title>Результаты</title><p>Результаты. Постинфарктное ремоделирование левого желудочка (ЛЖ) приводило не только к структурной перестройке ЛЖ, сопровождаемой дилатацией полости, истончением стенок полости, снижением сократительной способности миокарда, но и к изменению геометрической формы ЛЖ. Снижение сократительной способности миокарда ЛЖ сопровождалось нарушением эндотелий-зависимой вазодилатации сосудов, характеризующихся увеличением пульсативного и резистивного индексов, снижением чувствительности плечевой артерии к напряжению сдвига.</p></sec></abstract><trans-abstract xml:lang="en"/><kwd-group xml:lang="ru"><kwd>хроническая сердечная недостаточность</kwd><kwd>ремоделирование сердца</kwd><kwd>дисфункция эндотелия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chronic heart failure</kwd><kwd>heart remodeling</kwd><kwd>endothelial dysfunction</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Engelfriet PM, Hoogenveen RT, Boshuizen HC, et al. To die with of from heart failure: a difference that counts: is heart failure underrepresented in national mortality statistics? Eur J Heart Fail 2011; (13): 377-80.</mixed-citation><mixed-citation xml:lang="en">Engelfriet PM, Hoogenveen RT, Boshuizen HC, et al. To die with of from heart failure: a difference that counts: is heart failure underrepresented in national mortality statistics? Eur J Heart Fail 2011; (13): 377-80.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Sherazi S, Zaręba W. Diastolic heart failure: Predictors of mortality Cardiology Journal 2011; 18(3): 222-32.</mixed-citation><mixed-citation xml:lang="en">Sherazi S, Zaręba W. Diastolic heart failure: Predictors of mortality Cardiology Journal 2011; 18(3): 222-32.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Gaasch WH, Delorey DE, St John Sutton MG, Zile MR. Patterns of structural and functional remodeling of the left ventricle in chronic heart failure. Am J Cardiol 2008; 102(4): 459-62.</mixed-citation><mixed-citation xml:lang="en">Gaasch WH, Delorey DE, St John Sutton MG, Zile MR. Patterns of structural and functional remodeling of the left ventricle in chronic heart failure. Am J Cardiol 2008; 102(4): 459-62.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Desai RV, Meyer P, Ahmed MI, et al. Relationship between left and right ventricular ejection fractions in chronic advanced systolic heart failure: insights from the BEST trial. Eur J Heart Failure 2010; 13: 392-7.</mixed-citation><mixed-citation xml:lang="en">Desai RV, Meyer P, Ahmed MI, et al. Relationship between left and right ventricular ejection fractions in chronic advanced systolic heart failure: insights from the BEST trial. Eur J Heart Failure 2010; 13: 392-7.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J 2012; 33(14): 1750-7.</mixed-citation><mixed-citation xml:lang="en">Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J 2012; 33(14): 1750-7.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Nguyen JS, Lakkis NM, Bobek J, et al. Systolic and diastolic myocardial mechanics in patients with cardiac disease and preserved ejection fraction: impact of left ventricular filling pressure. J Am Soc Echocardiogr 2010; 23(12): 1273-80.</mixed-citation><mixed-citation xml:lang="en">Nguyen JS, Lakkis NM, Bobek J, et al. Systolic and diastolic myocardial mechanics in patients with cardiac disease and preserved ejection fraction: impact of left ventricular filling pressure. J Am Soc Echocardiogr 2010; 23(12): 1273-80.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Niebauer J. Effects of exercise training on inflammatory markers in patients with heart failure. Heart Fail Rev 2008; 13(1): 39-49.</mixed-citation><mixed-citation xml:lang="en">Niebauer J. Effects of exercise training on inflammatory markers in patients with heart failure. Heart Fail Rev 2008; 13(1): 39-49.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Fischer D, Rossa S, Landmesser U, et al. Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiactransplantation, or death. Eur Heart J 2005; 26: 65-9.</mixed-citation><mixed-citation xml:lang="en">Fischer D, Rossa S, Landmesser U, et al. Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiactransplantation, or death. Eur Heart J 2005; 26: 65-9.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bauersachs J, Widder JD. Endothelial dysfunction in heart failure. Pharmacological Reports 2008; 60:119-26.</mixed-citation><mixed-citation xml:lang="en">Bauersachs J, Widder JD. Endothelial dysfunction in heart failure. Pharmacological Reports 2008; 60:119-26.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Horn P, Cortese-Krott MM, Nicolas A, et al. Circulating microparticles carry a functional endothelial Nitric Oxide synthase that is decreased in patients with endothelial dysfunction. J Am Heart Assoc 2012; 2: e003764</mixed-citation><mixed-citation xml:lang="en">Horn P, Cortese-Krott MM, Nicolas A, et al. Circulating microparticles carry a functional endothelial Nitric Oxide synthase that is decreased in patients with endothelial dysfunction. J Am Heart Assoc 2012; 2: e003764</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Hsieh HJ, Liu CA, Huang B, et al. Shear-induced endothelial mechanotransduction: the interplay between reactive oxygen species (ROS) and nitric oxide (NO) and the pathophysiological implications. J Biomed Sci 2014 Jan 13; 21(1): 3. doi: 10.1186/1423-0127-21-3.</mixed-citation><mixed-citation xml:lang="en">Hsieh HJ, Liu CA, Huang B, et al. Shear-induced endothelial mechanotransduction: the interplay between reactive oxygen species (ROS) and nitric oxide (NO) and the pathophysiological implications. J Biomed Sci 2014 Jan 13; 21(1): 3. doi: 10.1186/1423-0127-21-3.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Deanfield J, Donald A, Ferri C, et al. Endothelial function and dysfunction. Part 1: Methodological issues for assessment in the different vascular beds: A statement by the Working group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005; 23(1): 7-16.</mixed-citation><mixed-citation xml:lang="en">Deanfield J, Donald A, Ferri C, et al. Endothelial function and dysfunction. Part 1: Methodological issues for assessment in the different vascular beds: A statement by the Working group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005; 23(1): 7-16.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation 2005; 111: 363-8.</mixed-citation><mixed-citation xml:lang="en">Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation 2005; 111: 363-8.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
